SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about newspaper publication

17 Dec 2024 Evaluate
Sun Pharmaceutical Industries has informed that pursuant to the NCLT Order dated November 14, 2024, the Company has published newspaper advertisements [All editions of Financial Express (in English) and Ahmedabad Edition of Financial Express (in Gujarati)] on December 17, 2024, containing information about the NCLT Convened Meeting of Equity Shareholders of the Company scheduled to be held on January 21, 2025 and E-Voting. Copies of newspaper clippings are attached as Annexure A, which is also available on the Company's website at www.sunpharma.com

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1847.30 12.90 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×